We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
-3.55%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$28.5B
AUM Growth
-$1.64B
Cap. Flow
-$541M
Cap. Flow %
-1.9%
Top 10 Hldgs %
23.41%
Holding
1,182
New
104
Increased
354
Reduced
497
Closed
123

Top Buys

Rank Stock Value
1
AMAT icon
Applied Materials
AMAT
+$94.3M
2
MSFT icon
Microsoft
MSFT
+$65.5M
3
LLY icon
Eli Lilly
LLY
+$58.4M
4
NVDA icon
NVIDIA
NVDA
+$58M
5
ABBV icon
AbbVie
ABBV
+$43.8M

Top Sells

Rank Stock Value
1
SLAB icon
Silicon Laboratories
SLAB
+$84.9M
2
ATVI
Activision Blizzard
ATVI
+$78.4M
3
BAC icon
Bank of America
BAC
+$64.2M
4
MA icon
Mastercard
MA
+$60.4M
5
MMM icon
3M
MMM
+$55.1M

Sector Composition

Rank Sector Weight
1 Technology 33.32%
2 Healthcare 19.18%
3 Consumer Discretionary 12.28%
4 Financials 8.16%
5 Industrials 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTW icon
1126
Willis Towers Watson
WTW
$30B
– –
-921
Closed -$217K
XPO icon
1127
XPO
XPO
$23.6B
– –
-10,600
Closed -$625K
XPRO icon
1128
Expro Ltd
XPRO
$1.72B
– –
-19,800
Closed -$351K
VRN
1129
DELISTED
Veren
VRN
– –
-180,300
Closed -$1.21M
QVCGA
1130
DELISTED
QVC Group Inc Series A
QVCGA
– –
-15,508
Closed -$767K
SCWX
1131
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
– –
-17,600
Closed -$127K
CERE
1132
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-233,680
Closed -$7.43M
NGM
1133
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-10,500
Closed -$27.2K
GOEV
1134
DELISTED
Canoo Inc. Class A Common Stock
GOEV
– –
-2,086
Closed -$460K
NSTG
1135
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-141,500
Closed -$573K
IMGN
1136
DELISTED
Immunogen Inc
IMGN
– –
-44,800
Closed -$845K
VRTV
1137
DELISTED
VERITIV CORPORATION
VRTV
– –
-22,300
Closed -$2.8M
NXGN
1138
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
– –
-119,300
Closed -$1.94M
SYNH
1139
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-44,200
Closed -$1.86M
NEX
1140
DELISTED
NexTier Oilfield Solutions Inc.
NEX
– –
-226,300
Closed -$2.02M
LSI
1141
DELISTED
Life Storage, Inc.
LSI
– –
-145,234
Closed -$19.3M
42 43 44 45
46

Similar funds

PHAM
Palisades Hudson Asset Management Fort Lauderdale, Florida $257M AUM 21.62% 1-Year Est. Return
HFRG
Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return
EBWM
Eagle Bluffs Wealth Management Columbia, Missouri $257M AUM 30.19% 1-Year Est. Return
GCCM
Gate City Capital Management Chicago, Illinois $257M AUM 37.12% 1-Year Est. Return
CIA
Corigliano Investment Advisers Raleigh, North Carolina $256M AUM 54.89% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
ACM
ADW Capital Management Miami Beach, Florida $257M AUM 11.22% 1-Year Est. Return
CCA
Cruiser Capital Advisors Stamford, Connecticut $257M AUM 65.27% 1-Year Est. Return

Axa's Q3 2023 Portfolio in Review

As of Q3 2023, Axa held 1,182 positions worth $28.5B, down 5.5% from $30.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Axa's Q3 2023 filing shows 104 new, 354 increased, 497 reduced and 123 closed positions. Its largest new stake was Invesco: 1,126,202 shares worth $16.4M. The largest sale was Silicon Laboratories, an estimated $84.9M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q3 2023 buy was Invesco: 1,126,202 shares worth $16.4M.
  • Axa added most to Applied Materials in Q3 2023, an estimated $94.3M increase.
  • Axa's biggest Q3 2023 reduction was Silicon Laboratories, cutting an estimated $84.9M.
  • Axa fully exited Life Storage, Inc. in Q3 2023, selling an estimated $19.3M.
  • Axa's ten largest holdings make up 23% of its $28.5B portfolio in Q3 2023.
  • Axa opened 104 new positions and closed 123 in Q3 2023.
  • Axa's portfolio value fell 5.5% quarter-over-quarter to $28.5B.

Based on Axa's 13F filing for Q3 2023, filed 14 Nov 2023.